biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Time Warp

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Nov 08, 2022 8:01pm

92 Views

Post# 35083912

RE:RE:RE:RE:RE:RE:Time Warp

Wair a minute, beenthere. You accuse me of convincing everybody to buy Bioasis and then to stay. Besides being the favoured characteristics of promotors, I actually told you all the things that were wrong, which promoters don't do.

Most people who complain about losing money actually still have a lot of shares that can still make them a lot of money.

So, what is your complaint? I lose track after a while.

jd

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec